Rockwell Medical, Inc. (RMTI)

Rockwell Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.61	15.66	8.98	10.1	13.28	48.68
Short-Term Investments	10.1	5.94	1.95	11.39	9.16	10
Cash & Short-Term Investments	23.71	21.6	10.94	21.49	22.44	58.68
Cash Growth	29.74%	97.55%	-49.12%	-4.22%	-61.76%	125.30%
Accounts Receivable	8.33	8.29	10.9	6.26	5.91	4.17
Receivables	8.33	8.29	10.9	6.26	5.91	4.17
Inventory	3.96	5.78	5.87	5.81	4.08	3.91
Prepaid Expenses	1.52	1.36	1.06	1.75	2.86	2.71
Total Current Assets	37.51	37.03	28.77	35.31	35.29	69.47
Property, Plant & Equipment	8.7	10.34	11.02	8.61	10.22	5.55
Goodwill	0.92	0.92	0.92	0.92	0.92	0.92
Other Intangible Assets	9.79	10.21	10.76	-	-	-
Other Long-Term Assets	0.56	0.71	0.71	1.8	2.14	1.81
Total Assets	57.49	59.21	52.17	46.64	48.57	77.75
Accounts Payable	1.52	2.87	4.52	4.05	3.74	4.16
Accrued Expenses	3.27	4.86	5.49	7.12	4.29	4.26
Short-Term Debt	0.46	0.27	0.24	0.5	0.44	-
Current Portion of Long-Term Debt	-	-	-	1.63	7.38	-
Current Portion of Leases	1.78	2.17	1.94	2.01	2	1.17
Current Unearned Revenue	1.95	2.51	2.79	1.8	2.32	2.33
Other Current Liabilities	0.6	1.42	1.66	0.59	0.8	0.89
Total Current Liabilities	9.58	14.09	16.64	17.69	20.97	12.79
Long-Term Debt	8.74	8.47	8.29	7.56	13.19	20.95
Long-Term Leases	2.15	2.63	2.96	4.67	5.89	1.82
Long-Term Unearned Revenue	-	1.43	2.98	2.6	5.99	8.02
Other Long-Term Liabilities	-	-	0.01	0.01	0.01	-
Total Liabilities	20.47	26.62	30.88	32.53	46.04	43.58
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	439.38	430.21	418.49	402.7	372.56	371.51
Retained Earnings	-402.44	-397.68	-397.2	-388.76	-370.08	-337.41
Comprehensive Income & Other	0.07	0.05	-0	0.16	0.05	0.06
Shareholders' Equity	37.02	32.59	21.29	14.11	2.54	34.17
Total Liabilities & Equity	57.49	59.21	52.17	46.64	48.57	77.75
Total Debt	13.13	13.54	13.44	16.36	28.9	23.94
Net Cash (Debt)	10.58	8.07	-2.5	5.13	-6.46	34.74
Net Cash Growth	158.35%	-	-	-	-	57.86%
Net Cash Per Share	0.31	0.26	-0.11	0.36	-0.76	5.05
Filing Date Shares Outstanding	39.41	34.06	29.33	12.55	8.54	8.51
Total Common Shares Outstanding	39.41	34.06	29.13	12.16	8.54	8.51
Working Capital	27.93	22.94	12.13	17.62	14.32	56.68
Book Value Per Share	0.94	0.96	0.73	1.16	0.30	4.02
Tangible Book Value	26.31	21.46	9.61	13.19	1.61	33.25
Tangible Book Value Per Share	0.67	0.63	0.33	1.08	0.19	3.91
Machinery	14.92	14.63	13.78	8.57	8.39	7.98
Leasehold Improvements	1.58	1.56	1.42	1.26	1.2	1.2

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q